APA (7th ed.) Citation

M, R., MA, B., C, S., P, D. M., SFA, D., M, G. D. F., . . . E, I. (2025). Proprotein convertase subtilisin/kexin type 9: A promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention. Frontiers in medicine, 12, 1521344. https://doi.org/10.3389/fmed.2025.1521344

Chicago Style (17th ed.) Citation

M, Rottura, et al. "Proprotein Convertase Subtilisin/kexin Type 9: A Promising Marker of Cardiovascular Risk in Post-menopausal Diabetic Women in Primary Prevention." Frontiers in Medicine 12 (2025): 1521344. https://doi.org/10.3389/fmed.2025.1521344.

MLA (9th ed.) Citation

M, Rottura, et al. "Proprotein Convertase Subtilisin/kexin Type 9: A Promising Marker of Cardiovascular Risk in Post-menopausal Diabetic Women in Primary Prevention." Frontiers in Medicine, vol. 12, 2025, p. 1521344, https://doi.org/10.3389/fmed.2025.1521344.